07:11 AM EDT, 07/29/2025 (MT Newswires) -- GeneDx Holdings ( WGS ) reported Q2 adjusted earnings Tuesday of $0.50 per diluted share, swinging from an adjusted loss of $0.08 per share a year earlier.

Analysts polled by FactSet expected $0.12.

Revenue for the quarter ended June 30 was $102.7 million, up from $68.9 million a year earlier.

Analysts surveyed by FactSet expected $85.4 million.

The company raised its 2025 revenue outlook to between $400 million and $415 million, from the previous range of $360 million to $375 million. Analysts polled by FactSet expect $369.4 million.

Shares of GeneDx Holdings ( WGS ) were up 26% in recent Tuesday premarket activity.